Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diethelm Tschöpe

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Diabetes and Its Complications|May 9, 2017
Can SGLT-2 inhibitors resolve the heart failure burden of diabetes mellitus - Is it empaglifozin or the class?Diethelm Tschöpe
International Journal of Endocrinology|June 20, 2015
Vascular Effects of Dietary Advanced Glycation End ProductsAlin Stirban, Diethelm Tschöpe
European Heart Journal|November 16, 2004
Impaired glucose tolerance-a new risk factor?Diethelm Tschöpe, Christoph Bode
Herz|June 14, 2006
[Dietary options in obesity and metabolic syndrome]Michaela Müller-Rösel, Diethelm Tschöpe
Herz|June 24, 2008
[Diabetes and the heart - revisited]Lars Rydén, Diethelm Tschöpe, Rolf Dörr
Herz|August 7, 2025
Cardiovascular diseases and diabetes-new focus on obesityRolf Dörr, Diethelm Tschöpe, Nikolaus Marx
Herz|September 30, 2022
Back to the roots of cardiometabolic careDiethelm Tschöpe, Rolf Dörr, Nikolaus Marx
Herz|September 2, 2004
Diabetes and the heartThomas F Lüscher, Lars Ryden, Diethelm Tschöpe
Diabetes & Vascular Disease Research|November 15, 2015
Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitusDiethelm Tschöpe, Peter Bramlage, Steffen Schneider, et al.
Cardiovascular Diabetology|February 4, 2015
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapyAnselm K Gitt, Peter Bramlage, Steffen Schneider, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Diabetes and Its Complications|May 9, 2017
Can SGLT-2 inhibitors resolve the heart failure burden of diabetes mellitus - Is it empaglifozin or the class?Diethelm Tschöpe
International Journal of Endocrinology|June 20, 2015
Vascular Effects of Dietary Advanced Glycation End ProductsAlin Stirban, Diethelm Tschöpe
European Heart Journal|November 16, 2004
Impaired glucose tolerance-a new risk factor?Diethelm Tschöpe, Christoph Bode
Herz|June 14, 2006
[Dietary options in obesity and metabolic syndrome]Michaela Müller-Rösel, Diethelm Tschöpe
Herz|June 24, 2008
[Diabetes and the heart - revisited]Lars Rydén, Diethelm Tschöpe, Rolf Dörr
Herz|August 7, 2025
Cardiovascular diseases and diabetes-new focus on obesityRolf Dörr, Diethelm Tschöpe, Nikolaus Marx
Herz|September 30, 2022
Back to the roots of cardiometabolic careDiethelm Tschöpe, Rolf Dörr, Nikolaus Marx
Herz|September 2, 2004
Diabetes and the heartThomas F Lüscher, Lars Ryden, Diethelm Tschöpe
Diabetes & Vascular Disease Research|November 15, 2015
Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitusDiethelm Tschöpe, Peter Bramlage, Steffen Schneider, et al.
Cardiovascular Diabetology|February 4, 2015
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapyAnselm K Gitt, Peter Bramlage, Steffen Schneider, et al.
Pageof 4